Pathstone Holdings »

Acumen Pharmaceuticals shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 480k 2.42
2024-03-31 $1.9M 480k 4.05
2023-12-31 $1.8M 479k 3.84

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Crowdstrike Hldgs Cl A (CRWD)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Franklin Resources
Rock Springs Capital Management
BlackRock
Millennium Management
Vanguard Group
Laurion Capital Management
T. Rowe Price Associates
Alyeska Investment Group
Geode Capital Management
Hudson Bay Capital Management
Pathstone Holdings
State Street Corporation
Jane Street
Two Sigma Advisers

View all funds holding Acumen Pharmaceuticals